152 related articles for article (PubMed ID: 36660721)
1. High tyrosine threonine kinase expression predicts a poor prognosis: a potential therapeutic target for endometrial carcinoma.
Cui CH; Wu Q; Zhou HM; He H; Wang Y; Tang Z; Zhang Y; Wang X; Xiao J; Zhang H
Ann Transl Med; 2022 Dec; 10(24):1352. PubMed ID: 36660721
[TBL] [Abstract][Full Text] [Related]
2. Integrated multi-omics analyses and functional validation reveal TTK as a novel EMT activator for endometrial cancer.
Miao Y; Konno Y; Wang B; Zhu L; Zhai T; Ihira K; Kobayashi N; Watari H; Jin X; Yue J; Dong P; Fang M
J Transl Med; 2023 Feb; 21(1):151. PubMed ID: 36829176
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of TTK expression is associated with poor prognosis and immune infiltration in endometrial cancer patients.
Du H; Zhang L; Chen J; Chen X; Qiang R; Ding X; Wang Y; Yang X
Cancer Cell Int; 2024 Jan; 24(1):20. PubMed ID: 38195567
[TBL] [Abstract][Full Text] [Related]
4. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
5. Silencing TTK expression inhibits the proliferation and progression of prostate cancer.
Chen S; Wang J; Wang L; Peng H; Xiao L; Li C; Lin D; Yang K
Exp Cell Res; 2019 Dec; 385(1):111669. PubMed ID: 31605696
[TBL] [Abstract][Full Text] [Related]
6. In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.
Khedkar HN; Wang YC; Yadav VK; Srivastava P; Lawal B; Mokgautsi N; Sumitra MR; Wu ATH; Huang HS
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072728
[TBL] [Abstract][Full Text] [Related]
7. [Expression of tyrosine and threonine protein kinase in carcinogenic process of colorectal cancer and its relationship with prognosis].
Zhang XL; Han WX; Ma YM; Baohan HW; Zhao XH; Wang HY
Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):172-177. PubMed ID: 28316214
[No Abstract] [Full Text] [Related]
8. Identification of hub genes associated with prognosis, diagnosis, immune infiltration and therapeutic drug in liver cancer by integrated analysis.
Lei X; Zhang M; Guan B; Chen Q; Dong Z; Wang C
Hum Genomics; 2021 Jun; 15(1):39. PubMed ID: 34187556
[TBL] [Abstract][Full Text] [Related]
9. Key role of dual specificity kinase TTK in proliferation and survival of pancreatic cancer cells.
Kaistha BP; Honstein T; Müller V; Bielak S; Sauer M; Kreider R; Fassan M; Scarpa A; Schmees C; Volkmer H; Gress TM; Buchholz M
Br J Cancer; 2014 Oct; 111(9):1780-7. PubMed ID: 25137017
[TBL] [Abstract][Full Text] [Related]
10. TTK predicts triple positive breast cancer prognosis and regulates tumor proliferation and invasion.
Gao YH; Qu SS; Cao LQ; Yao M
Neoplasma; 2022 Mar; 69(2):274-282. PubMed ID: 34846157
[TBL] [Abstract][Full Text] [Related]
11. Mitotic checkpoint kinase Mps1/TTK predicts prognosis of colon cancer patients and regulates tumor proliferation and differentiation via PKCα/ERK1/2 and PI3K/Akt pathway.
Zhang L; Jiang B; Zhu N; Tao M; Jun Y; Chen X; Wang Q; Luo C
Med Oncol; 2019 Nov; 37(1):5. PubMed ID: 31720873
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent and selective covalent threonine tyrosine kinase (TTK) inhibitor.
Sun Y; Chen Z; Liu G; Chen X; Shi Z; Feng H; Yu L; Li G; Ding K; Huang H; Zhang Z; Xu S
Bioorg Chem; 2024 Feb; 143():107053. PubMed ID: 38159497
[TBL] [Abstract][Full Text] [Related]
13. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
[TBL] [Abstract][Full Text] [Related]
14. Threonine and tyrosine kinase may serve as a prognostic biomarker for gallbladder cancer.
Xie Y; Lin JZ; Wang AQ; Xu WY; Long JY; Luo YF; Shi J; Liang ZY; Sang XT; Zhao HT
World J Gastroenterol; 2017 Aug; 23(31):5787-5797. PubMed ID: 28883705
[TBL] [Abstract][Full Text] [Related]
15. Phosphotyrosine picked threonine kinase stimulates proliferation of human osteosarcoma cells
Wang ZX; Ren SC; Ren J
Arch Med Sci; 2022; 18(3):775-785. PubMed ID: 35591845
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of
Tsai YM; Wu KL; Chang YY; Hung JY; Chang WA; Chang CY; Jian SF; Tsai PH; Huang YC; Chong IW; Hsu YL
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121246
[TBL] [Abstract][Full Text] [Related]
17. TTK inhibitor promotes radiosensitivity of liver cancer cells through p21.
Zhang H; Yao W; Zhang M; Lu Y; Tang J; Jiang M; Mou X; You G; Liang X
Biochem Biophys Res Commun; 2021 Apr; 550():84-91. PubMed ID: 33689884
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis.
Yang L; Cui Y; Sun X; Wang Y
Aging (Albany NY); 2021 Jan; 13(3):4564-4589. PubMed ID: 33495413
[TBL] [Abstract][Full Text] [Related]
19. Key factors mediated by PI3K signaling pathway and related genes in endometrial carcinoma.
Liu Z; Hong Z; Ma H; Yu D; Qu P
J Bioenerg Biomembr; 2020 Dec; 52(6):465-473. PubMed ID: 33159265
[TBL] [Abstract][Full Text] [Related]
20. IL-2-induced expression of TTK, a serine, threonine, tyrosine kinase, correlates with cell cycle progression.
Schmandt R; Hill M; Amendola A; Mills GB; Hogg D
J Immunol; 1994 Jan; 152(1):96-105. PubMed ID: 8254211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
